Laser Acupuncture in Rheumatoid Arthritis Geriatric Patients

Rheumatoid Arthritis Clinical Trial

Official title:

Laser Acupuncture in Rheumatoid Arthritis Geriatric Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04758689
• Other study ID #: REC/002-2021
• Status: Completed
• Phase: N/A
• Start date: November 20, 2020
• Est. completion date: December 22, 2020

Study information

• Verified date: May 2021
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Studying the effect of laser acupuncture on geriatric patients with rheumatoid arthritis

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: December 22, 2020
• Est. primary completion date: December 20, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years to 75 Years

Eligibility

Inclusion Criteria:

• Patients referred from physician (immunologist) diagnosed with rheumatoid arthritis.

Exclusion Criteria:

• Patients having the disease overlapping with other connective tissue diseases, such as systematic lupus erythromatosus and systematic sclerosis.

• History of malignancies.

Related Conditions & MeSH terms

• Arthritis
• Arthritis, Rheumatoid
• Rheumatoid Arthritis

Intervention

Combination Product:
• Laser, exercise, and methotrexate
Laser therapy at acupuncture points, aerobic exercise, and methotrexate
• Exercise, and methotrexate
Aerobic exercise, and methotrexate

Locations

Country	Name	City	State
Egypt	A. Sedky	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Interleukin 6 (IL-6)	interleukin 6	Baseline
Primary	Interleukin 6 (IL-6)	interleukin 6	4 weeks
Primary	Malondialdehyde (MDA)	malondialdehyde	Baseline
Primary	Malondialdehyde (MDA)	malondialdehyde	4 weeks
Primary	Adenosine Triphosphate (ATP)	adenosine triphosphate	Baseline
Primary	Adenosine Triphosphate (ATP)	adenosine triphosphate	4 weeks
Primary	C-Reactive Protein (CRP)	C-reactive protein	Baseline
Primary	C-Reactive Protein (CRP)	C-reactive protein	4 weeks
Secondary	Rheumatoid Arthritis Quality of Life (RAQoL)	rheumatoid arthritis quality of life	Baseline
Secondary	Rheumatoid Arthritis Quality of Life (RAQoL)	rheumatoid arthritis quality of life	4 weeks
Secondary	Health Assessment Questionnaire (HAQ)	health assessment questionnaire	Baseline
Secondary	Health Assessment Questionnaire (HAQ)	health assessment questionnaire	4 weeks